GlaxoSmithKline is hiring over 100 employees for its expanding manufacturing site in North Carolina.
A spokesperson told in-Pharmatechnologist.com the facility in Zebulon, NC is adding another assembly line for production of Advair and Ellipta dry powder inhalers and other respiratory drugs Breo, Anoro, and Incruse. It will take on 100 employees this year (some of the positions have already been filled), and another 30 to 40 in 2016.
The company broke ground in March on its new Ellipta inhaler assembly line, adding 65,000 sq ft. It is expected to begin manufacturing in January 2017.
Zebulon currently employs 850 people, including 700 site staff and support groups, and the rest as central staff.
The facility manufactures tablets for Imitrex, Epivir, Combivir, Wellbutrin SR/Zyban, Zofran, Valtrex, Trizivir, Zovirax, Lamictal Tafinlar, Mekinist, Tivicay and Triumeq, and inhalers for Ventolin, Serevent, Flovent, Advair and Breo. It also packages tablets and capsules made elsewhere, including Lovaza, Avodart, and Jayln.
Copyright - Unless otherwise stated all contents of this web site are © 2017 - William Reed Business Media SAS - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions
Welcome to in-PharmaTechnologist's monthly round up of who's been moving where in the small-molecule manufacturing world. The...
Eli Lilly is conducting several experiments on the International Space Station (ISS) US National Laboratory over the...
The world’s largest modular cGMP biopharmaceutical manufacturing facility came online this week in Wuhan, China.
Valeant, Rentschler, Celgene, MannKind, and Syngene are among those welcoming new leaders for 2016. Oh, and Turing...